Advertising
We regulate advertisements for therapeutic goods. You need to know if that includes the product you intend to advertise.
Last updated
-
Advertising basics
Information about what is considered advertising, if advertising is allowed for your product and using the Advertising Code. -
Applying the Advertising Code
The Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021 (the Code) outlines requirements when advertising to the public. -
Specialised advertising issues and topics
Learn about the requirements for advertising therapeutic goods in specific circumstances, such as social media, and for specific types of products, like weight loss injections. -
Understanding social media advertising rules
Find out how therapeutic goods legislation applies to social media posts, comments, hashtags, and paid promotions. Includes practical resources for businesses, influencers and consumers. -
Advertising legal framework
Information on the legal and regulatory framework underpinning our rules on advertising therapeutic goods. -
Advertising consultations
Find information on consultation in relation to Therapeutic Goods Advertising. -
Make an advertising enquiry
Get help understanding therapeutic goods advertising requirements and how the rules apply to your advertising activities.
Compliance
-
Compliance and enforcement
We monitor and enforce compliance with laws that regulate health products. -
Advertising compliance and reports
How we manage advertising compliance, and where to find information about enforcement outcomes. -
Report non-compliant advertising
Report non-compliant advertisement for a medicine, medical device or any other type of therapeutic good, using our online portal.
Latest alerts
-
We are advising consumers that ‘Pharmatech’ branded MK-677 capsules (containing ibutamoren) may pose a serious risk to your health and should not be taken.
-
TGA is issuing a safety advisory about the importation of unregistered GLP-1 products that are being promoted online for weight-loss.
-
Weleda Australia Pty Ltd is recalling one batch of Weleda Baby Teething Powder following a complaint that a fragment of glass was found in one bottle of this product.
Latest articles
-
Court orders CDA Clinics QLD and its former director to pay $6.95 million for unlawful advertising of medicinal cannabis
The Federal Court of Australia has ordered CDA Clinics QLD Pty Ltd (CDA Clinics) to pay $6.5 million in civil penalties for the unlawful advertising of medicinal cannabis to the public. -
Therapeutic Goods (Poisons Standard) (COVID-19 Vaccine—Pfizer) (SARS-CoV-2 Spike Protein (mRNA) XFG) Labelling Exemption 2026
This instrument is made under section 39 of the current Poisons Standard. -
More than $126k in infringement notices for unlawful importation and advertising of prescription-only medicines
We have issued 12 infringement notices totalling $126,720 to 2 companies and 5 individuals for the alleged unlawful importation and advertising of prescription-only medicines.
Latest publications
-
This plan outlines our compliance and education priorities for 2024-2025.
-
The strategy outlines the approach we will use to identify, engage with, and educate stakeholders about regulatory requirements and our compliance outcomes.
-
Overview of therapeutic goods advertising complaints handling and compliance for 2022-23